Trainee pharmacists at Boots in England and Northern Ireland will get a pay increase from 1st August.
The new pay rates agreed between the Pharmacists' Defence Association (PDA) Union and Boots was announced on Tuesday (4 July).
The joint statement released by Boots and PDA Union said: "Following discussions, we are pleased to announce that there will be a pay increase for Trainee
Pharmacists, in England and Northern Ireland, commencing in role this summer."
Trainee Pharmacists working in Boots Pharmacies in Wales are employed directly by the NHS and are therefore outside the scope of the pay negotiations between
Boots and the PDA Union.
Funding for each Boots Trainee Pharmacist in Scotland is at a higher level and Boots continues to pass on the fully funded amount as salary to those team members
Boots pharmacists will receive a pay rise of 4.5 per cent as the pharmacy multiple and PDA Union jointly announce this year's pay settlement.
Following discussions between Boots management services and the PDA Union negotiators, the agreement was reached in relation to this year's pay claim, effective
from 1 November 2022.
The union also announced that those who have already had a pay increase on or since 1 August 2022, where that increase has been less than 4.5 per cent, a 'top up'
increase will be provided, from 1 November 2022, to ensure that all eligible members of the bargaining unit receive a pay increment of not less than 4.5 per cent in
2022.
Boots and the PDA Union have agreed an increase to the pay of those above the maximum market range by 4 per cent with an additional 0.5 per cent non-consolidated
payment.
Boots and the Pharmacists' Defence Association (PDA) Union have released a joint statement to confirm that there will be a pay increase for trainee
pharmacists in England and Northern Ireland from April 2024.
From 1 April 2024, the new hourly pay rate for trainee pharmacists working at Boots pharmacies will be £12.69 for Zone A in England/Northern Ireland, £13.79
for Zone B in England and £14.05 for Zone C in England.
"This increase will be applied centrally in the April pay run," said the statement from the Boots and the PDA Union.
Team members can see the new rate of pay in the Benefits Box during the annual enrolment window from 20 February 2024, it added.
In August 2023, pay for trainee pharmacists at Boots in England and Northern Ireland was increased to £11.64 per hour for Zone A, £12.77 per hour for Zone B
and £12.88 per hour for Zone C.
Boots UK will offer a staring salary of £42,000 per annum to newly qualified pharmacists joining the pharmacy chain.
The company also revealed that "in addition, any existing pharmacists in the bargaining unit currently receiving less than £43k."
The newly announced hike in the salary - following an agreement reached between the multiple and and the Pharmacist Defence Association - will be effective from
1 August 2022.
"This enhanced offer for Newly Qualified Pharmacists and further investment in those in the early stages of their careers at Boots is a key part of our commitments
to pharmacists," the company said.
Boots and PDA Union also announced in a joint statement that they will conduct a further formal review of all pharmacists' pay in accordance with the collective
agreement, effective from 1 November 2022.
The Pharmacists' Defence Association (PDA) has reiterated its call for all pharmacists working at Boots to join the PDA Union to support the collective voice of the profession within the company.
It said this would enable PDA to send direct communications to pharmacists working at Boots and keep them up to date with key matters impacting their work life.
Currently, the association uses the company communication channels to cascade key information to the non-member pharmacists, however, it fears such measures can be
disrupted by management.
Besides, having more member pharmacists at Boots would strengthen their "negotiating power", PDA said.
Usdaw, one of the major trade unions in the UK, has sought assurances for its members working in Boots, following reports that the parent company of the iconic health and beauty retailer and pharmacy chain is considering putting the business on sale next year.
Walgreen Boots Alliance (WBA), the US health group that owns a stake in Boots UK since 2012, is reportedly lining up Goldman Sachs to explore the sale of business
with potential valuation of £10 billion.
Currently, the process is thought to be solely exploratory and may not necessarily convert into the sale of the 172-year-old firm.
Usdaw national officer, Daniel Adams, said: "We note that the company declined to comment on speculation, but acknowledged that the group's strategic direction 'includes a more pointed focus on North America and on healthcare'.
After a series of internal pay negotiations and conciliation meetings, Boots has made a revised pay offer to its pharmacists.
With the new development, the Pharmacists' Defence Association (PDA) has urged its members at Boots to "urgently respond to the Boots pay negotiations update survey on the current pay offer."
It encouraged the members to complete the short survey sent to them via email.
Last week, the PDA Reps Network in Boots hosted a series of virtual meetings for members that work at the company.
As the element of the negotiations with Advisory, Conciliation and Arbitration Service (ACAS) are ongoing, PDA could not provide more details about these meetings.
The Pharmacists' Defence Association (PDA) Union has reached a deal for its members working at Boots, covering 6,000 pharmacists employed by the British retailer and pharmacy chain.
As per the agreement, union members working at the multiple will receive a 2 per cent pay rise effective from November 1, 2021, the two entities said in a joint statement.
The settlement, reached under the guidance of Advisory, Conciliation and Arbitration Service (ACAS), covers provisionally registered pharmacists, pharmacists and pharmacist store managers in the bargaining unit for which the PDAU is recognised.
There will be improved benefits for those at the beginning of their careers as "all pharmacists qualifying in 2021 will be paid at least £38k gross FTE, including those who would otherwise be ineligible due to the 1st August cut-off."
The Pharmacists' Defence Association (PDA) has announced that it will support its member impacted by the decision to close 300 more Boots pharmacies.
After the announcement of closure of 300 Boots pharmacies over the next year, the association believes this is approximately one out of every eight current
Boots pharmacy locations.
The company has insisted that the objective of this exercise is not to make existing pharmacist employees redundant, and they hope to be able to redeploy
individuals into nearby alternative locations. However, PDA believes that it is unlikely that suitable alternative roles will be available for all and
redundancy is a possibility for some.
The PDA Union will provide pharmacists with information, support, and representation as part of the recognition agreement so that members are aware of and
can exercise their rights at work. PDA officials will be in continued dialogue with the company throughout this closure programme.
In significant development, the Pharmacists' Defence Association (PDA) has advised its Boots members to challenge the "trustees' decision to end the
ability to take an unreduced pension from age 60 by submitting complaints through the scheme's two-stage internal disputes procedure".
The issue centers around the alterations made to pension scheme rules without the adequate disclosure to scheme members or their representatives.
The PDA has drafted template letters to assist scheme members in response to undisclosed changes during a buyout process, sparking legal challenges and demands
for transparency from Boots and scheme trustees.
Paul Moloney, National Officer of the PDA Union leading the campaign, expressed concern over the sudden withdrawal of the right to an unreduced pension from age 60.
"We have always maintained that members had a right under the rules to draw an unreduced pension from age 60," Moloney stated.
Members of the Pharmacists' Defence Association (PDA) who have benefits in the Boots Pension Scheme have sought support from their union following the recent
communications from the trustees about the removal of the option to retire at 60 without a reduced pension.
The company claimed that retirement between 60-65 years old without a reduced pension was a discretionary benefit, and it has ended with the buy-in deal with Legal
and General.
However, PDA members believe there is insufficient evidence to fully support this claim, and therefore they are questioning whether this option should have been
secured as part of the buy in and not ended with immediate effect.
PDA Union national officer, Paul Moloney said: "Instead, we believe benefit statements issued to members, at the very least are contradictory, and clearly state
that a full pension will be payable from a member's 60th birthday, with no reference to this benefit being discretionary and therefore subject to a regular
review by the trustees. Instead, the benefit statements give the impression that an unreduced pension from 60 is a right with no indication that retirement plans
should not be based on the benefit statements."
Too many unreasonable demands placed on pharmacists by employers affect their health and wellbeing at work, a stress and wellbeing survey conducted by The Pharmacists' Defence Association (PDA) Union revealed.
The survey, conducted during Autumn 2021, covered views of over 2,000 pharmacists employed by big multiples - Lloyds, Boots, and Well.
This survey used questions developed by the Health and Safety Executive (HSE), which enabled the union to understand more about stress and wellbeing in three of the
largest community pharmacy multiples.
Analysing the survey, the PDA said that some pharmacists working for each of the three employers highlighted "unachievable targets, unrealistic time pressures, and
most worrying of all reported numerous instances of bullying and harassment."
An overwhelming majority of the respondents reflected personal sacrifices made by the pharmacists to ensure patient services are not impacted by the poor conditions
and environments in some pharmacies.